|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.300 SEK | +0.39% |
|
-3.35% | -37.20% |
| 17/06 | Axichem AB Elects Michael Engstrom As Chairman Of The Board | RE |
| 12/06 | Calendar Monday June 15 - Friday June 19 | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.36M | 5.01M | 1.81M | 8.57M | 18.45M | |||||
Total Revenues | 4.36M | 5.01M | 1.81M | 8.57M | 18.45M | |||||
Cost of Goods Sold, Total | 3.45M | 1.19M | 400K | 1.49M | 9.36M | |||||
Gross Profit | 909K | 3.82M | 1.41M | 7.08M | 9.08M | |||||
Selling General & Admin Expenses, Total | 12.97M | 14.76M | 15.54M | 18.15M | 21.12M | |||||
Depreciation & Amortization - (IS) | 2.47M | 3.51M | 3.83M | 4.28M | 4.9M | |||||
Other Operating Expenses | 534K | 91K | -642K | 485K | 560K | |||||
Other Operating Expenses, Total | 15.98M | 18.36M | 18.73M | 22.91M | 26.57M | |||||
Operating Income | -15.07M | -14.54M | -17.32M | -15.83M | -17.49M | |||||
Interest Expense, Total | -2K | -2.69M | -3.47M | -1.96M | -118K | |||||
Interest And Investment Income | 14K | - | - | - | - | |||||
Net Interest Expenses | 12K | -2.69M | -3.47M | -1.96M | -118K | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | -15.06M | -17.24M | -20.79M | -17.78M | -17.61M | |||||
EBT, Incl. Unusual Items | -15.06M | -17.24M | -20.79M | -17.78M | -17.61M | |||||
Income Tax Expense | 35K | 25K | 25K | 32K | 27K | |||||
Earnings From Continuing Operations | -15.09M | -17.26M | -20.81M | -17.82M | -17.64M | |||||
Net Income to Company | -15.09M | -17.26M | -20.81M | -17.82M | -17.64M | |||||
Minority Interest | - | 3K | 3K | 2K | 3K | |||||
Net Income - (IS) | -15.09M | -17.26M | -20.81M | -17.81M | -17.63M | |||||
Net Income to Common Incl Extra Items | -15.09M | -17.26M | -20.81M | -17.81M | -17.63M | |||||
Net Income to Common Excl. Extra Items | -15.09M | -17.26M | -20.81M | -17.81M | -17.63M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Basic EPS - Continuing Operations | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Basic Weighted Average Shares Outstanding | 16.34M | 16.54M | 20.3M | 38.53M | 59.11M | |||||
Net EPS - Diluted | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Diluted EPS - Continuing Operations | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Diluted Weighted Average Shares Outstanding | 16.34M | 16.54M | 20.3M | 38.53M | 59.11M | |||||
Normalized Basic EPS | -0.58 | -0.65 | -0.64 | -0.29 | -0.19 | |||||
Normalized Diluted EPS | -0.58 | -0.65 | -0.64 | -0.29 | -0.19 | |||||
Supplemental Items | ||||||||||
EBITDA | -13.51M | -12.44M | -15.1M | -13.48M | -15.02M | |||||
EBITA | -13.54M | -12.48M | -15.13M | -13.5M | -15.02M | |||||
EBIT | -15.07M | -14.54M | -17.32M | -15.83M | -17.49M | |||||
EBITDAR | - | - | - | - | - | |||||
Total Revenues (As Reported) | 4.44M | 5.22M | 2.68M | 8.96M | 19.04M | |||||
Effective Tax Rate - (Ratio) | -0.23 | -0.14 | -0.12 | -0.18 | -0.15 | |||||
Total Current Taxes | 35K | 25K | 25K | 32K | 27K | |||||
Normalized Net Income | -9.41M | -10.77M | -12.99M | -11.11M | -11M | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 910K | 1.4M | 1.62M | 1.93M | 2.42M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - |
- Stock Market
- Stocks
- AXIC A Stock
- Financials aXichem AB
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















